In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

This content is currently on FREE ACCESS

Role of biomarkers in CVD intensive preventive therapy among T2DM - current guidelines and future perspectives.

Session Biomarker targeted approach in preventing heart failure among patients with diabetes

Speaker Carolyn Sp Lam

Event : Heart Failure 2018

  • Topic : heart failure
  • Sub-topic : Chronic Heart Failure – Prevention
  • Session type : Satellite Symposium
  • Sponsored by Roche

This content is currently on FREE ACCESS

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are